Last Updated: 2024/12/01

医薬品製剤技術 (JP Patent Analysis Report) (JP SDGs Patent Report)

The Theme Code "医薬品製剤技術" had 123 patent application filings in the most recent period (2023-01-01 to 2023-03-31). This is a significantly decreased of -720 filings (-85.4%) over 843 they had in the same period of the previous year (2022-01-01 to 2022-03-31).

The highest number of filings in 2017 with 5,306 cases, and their lowest number in 2022 with 3,260 cases.

The mean of the number of filings over the last 5 years (2018 to 2023, 21,346 cases in total) is 3,558, and the median is 3,840. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.

Filing information for the last 5 years (2018 to 2023)
Index Value
Average 3,558 patents
Std Dev 1,573
COV 0.4

Filing trends for the last 3 years
Year Cases YOY
2022 year 3,260 cases -14.55 %
2021 year 3,815 cases -1.32 %
2020 year 3,866 cases -21.29 %

This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 医薬品製剤技術[4C076] for the period of the last 10 years (2014-01-01 to 2024-11-30). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.

This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.

This report includes basic information to help you understand the IP strategy and management of 医薬品製剤技術, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.

Article supervision: Patent attorney Yoshiyuki Ose
Article supervised by: Yoshiyuki Ose (Japanese Patent Attorney)    

He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.

After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..

Introduction

The concept of the "IP landscape" (IPL) has been attracting attention recently.

An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.

IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.

After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.

Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.

Foreign Patent Analysis Report

By clicking, you can check the patent application trends in each country of 医薬品製剤技術.

Patent Filing Trends in Each Country

Foreign Patent Analysis Report

The following foreign patent analysis reports have been found for 医薬品製剤技術. The trends of patent filings of 医薬品製剤技術 for each country can be found by clicking on the Applicant/Patent Holder name next to each country.

Patent Filing Trends in Each Country
Country Applicant / Patent Holder

医薬品製剤技術, Changes in the Number of JP Patents/Patent Applications

The changes in the number of patent filings of 医薬品製剤技術 over the last 20 years (JP) are shown below.

The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.

In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.

Counting of the Number of Cases using the Patent Mapping Function

By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology.

You can select a graph type from the menu on the upper left. Data can be output as a file to the clipboard, or in CSV format or TSV format. You can also output graph images as files in the SVG, PNG, and JPG formats. For the terms of use when using the data, please see "About this Site."

Patent Landscape ({{ld.d.db_name | country_map: 'en'}})

Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.

The patent landscape for 医薬品製剤技術 gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).

By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.

In addition, by visually representing the patent data in this manner, you can convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.

In Patent Integration, you can check the specifics of a patent filing by clicking anywhere on the patent landscape screen. You can also quickly check the position of each applicant for each technical field by cross-referencing with other keywords and patent classifications. You can use it as a guide when considering hypotheses about each company's IP strategy on the IP Landscape. You can also use it for higher-grade intellectual property activities. It has reasonable pricing and a simple user interface that is easy for beginners to handle.

Visualization of Technical Position

The patent landscape allows you to analyze, without any hassle, what patent applications have been filed and what technical position is to be established.

Characteristic Terms (Importance)

The following is a list of words (characteristic terms) often used in 医薬品製剤技術 patent applications. Characteristic terms with a higher importance are used in more patents/patent applications.

{{item.label}} ({{ld.floor (item.weight * 100 / ld.word_weight_max)}})

Search Set (Analysis Patents)

This patent analysis report was created for a patent search set of 40,499 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.

Patent Database
JP Publications/Granted Patents
Patent Search Formula
Theme Code:
医薬品製剤技術[4C076]
Patent Analysis Period
2014-01-01〜2024-11-30
Number of Patents
40,499 patents

Analysis results are determined on the basis of patent gazette data issued by the patent office in each country.

Same industry / competition company information (JP)

The patent information of the higher applicant in the technical theme 医薬品製剤技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme.

Introduction of patent search function

Competitive analysis can be performed in a short time by using various search functions such as applicant, filing date, and similar patent search.

Trends in filing of joint patent applications in the last 3 years (2022 to 2024).

Comparing the number of applications of each company, 大正製薬株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 37 cases, followed by 久光製薬株式会社 with 24 cases.

Trends in filing of joint patent applications for the target period (2014 to 2024).

Comparing the number of applications of each company, ロート製薬株式会社 has the highest number of joint applications in the last for the target period (2014 to 2024) with 457 cases, followed by 小林製薬株式会社 with 363 cases.

Trends in filing of joint patent applications for the target period (2014 to 2024).
Name Cases
ロート製薬株式会社 457 cases
小林製薬株式会社 363 cases
ノバルティスアーゲー 351 cases
興和株式会社 236 cases
大正製薬株式会社 226 cases
ライオン株式会社 218 cases
花王株式会社 171 cases
武田薬品工業株式会社 133 cases
久光製薬株式会社 132 cases
日東電工株式会社 70 cases
株式会社資生堂 26 cases

Same industry / competition company, Change in the Number of JP Patents

Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.

You can select a graph type from the menu on the upper left. Data can be output as a file to the clipboard, or in CSV format or TSV format. You can also output graph images as files in the SVG, PNG, and JPG formats. For the terms of use when using the data, please see "About this Site."

Top company information (JP)

The patent information of the higher applicant in the technical theme 医薬品製剤技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme.

Search for Coapplicants

Patent integration allows you to find coapplicants in a short amount of time.

Trends in filing of joint patent applications in the last 3 years (2022 to 2024).

among the top coapplicants, 大正製薬株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 37 cases, followed by ロート製薬株式会社 with 23 cases.

Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Name Cases
大正製薬株式会社 37 cases
ロート製薬株式会社 23 cases
ノバルティスアーゲー 21 cases
花王株式会社 17 cases
ライオン株式会社 13 cases
武田薬品工業株式会社 3 cases

Trends in filing of joint patent applications for the target period (2014 to 2024).

among the top coapplicants, ロート製薬株式会社 has the highest number of joint applications in the last for the target period (2014 to 2024) with 457 cases, followed by ノバルティスアーゲー with 351 cases.

Trends in filing of joint patent applications for the target period (2014 to 2024).
Name Cases
ロート製薬株式会社 457 cases
ノバルティスアーゲー 351 cases
大正製薬株式会社 226 cases
ライオン株式会社 218 cases
花王株式会社 171 cases
武田薬品工業株式会社 133 cases
日東電工株式会社 70 cases

Top company, Change in the Number of JP Patents

Below is a ranking of the number of JP patent applications by 医薬品製剤技術’s top 7 coapplicants over the last 20 years.

Below is a patent map showing the changes in the numbers of JP patent filings by 医薬品製剤技術’s top 7 coapplicants over the last 20 years.

You can select a graph type from the menu on the upper left. Data can be output as a file to the clipboard, or in CSV format or TSV format. You can also output graph images as files in the SVG, PNG, and JPG formats. For the terms of use when using the data, please see "About this Site."

Top company Details (JP)

Trends in filing of joint patent applications with 大正製薬株式会社

医薬品製剤技術 filed 226 joint applications with 大正製薬株式会社 for the analysis period (2014 to 2024).

The mean of the number of filings over the last 5 years (2018 to 2023, 80 cases in total) is 13.3, and the median is 11.0. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.

The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 42 cases, and their lowest number in 2019 with 8 cases.

Filing information for the last 5 years (2018 to 2023)
Index Value
Average 13.3 patents
Std Dev 5.1
COV 0.4
Filing trends for the last 3 years
Year Cases YOY
2022 year 17 cases -26.09 %
2021 year 23 cases +130 %
2020 year 10 cases +25.00 %

Trends in filing of joint patent applications with ライオン株式会社

医薬品製剤技術 filed 218 joint applications with ライオン株式会社 for the analysis period (2014 to 2024).

The mean of the number of filings over the last 5 years (2018 to 2023, 92 cases in total) is 15.3, and the median is 14.0. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.

The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2017 with 36 cases, and their lowest number in 2021 with 5 cases.

Filing information for the last 5 years (2018 to 2023)
Index Value
Average 15.3 patents
Std Dev 10.9
COV 0.7
Filing trends for the last 3 years
Year Cases YOY
2022 year 10 cases +100 %
2021 year 5 cases -79.2 %
2020 year 24 cases +33.3 %

Trends in filing of joint patent applications with ロート製薬株式会社

医薬品製剤技術 filed 457 joint applications with ロート製薬株式会社 for the analysis period (2014 to 2024).

The mean of the number of filings over the last 5 years (2018 to 2023, 193 cases in total) is 32.2, and the median is 15.5. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.

The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2018 with 74 cases, and their lowest number in 2022 with 12 cases.

Filing information for the last 5 years (2018 to 2023)
Index Value
Average 32.2 patents
Std Dev 27.3
COV 0.8
Filing trends for the last 3 years
Year Cases YOY
2022 year 12 cases -29.41 %
2021 year 17 cases +21.43 %
2020 year 14 cases -79.1 %

Trends in filing of joint patent applications with ノバルティスアーゲー

医薬品製剤技術 filed 351 joint applications with ノバルティスアーゲー for the analysis period (2014 to 2024).

The mean of the number of filings over the last 5 years (2018 to 2023, 153 cases in total) is 25.5, and the median is 22.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.

The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 64 cases, and their lowest number in 2022 with 19 cases.

Filing information for the last 5 years (2018 to 2023)
Index Value
Average 25.5 patents
Std Dev 15.0
COV 0.6
Filing trends for the last 3 years
Year Cases YOY
2022 year 19 cases 0
2021 year 19 cases -26.92 %
2020 year 26 cases -31.6 %

Trends in filing of joint patent applications with 武田薬品工業株式会社

医薬品製剤技術 filed 133 joint applications with 武田薬品工業株式会社 for the analysis period (2014 to 2024).

The mean of the number of filings over the last 5 years (2018 to 2023, 67 cases in total) is 11.2, and the median is 10.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.

The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2017 with 27 cases, and their lowest number in 2022 with 3 cases.

Filing information for the last 5 years (2018 to 2023)
Index Value
Average 11.2 patents
Std Dev 8.5
COV 0.8
Filing trends for the last 3 years
Year Cases YOY
2022 year 3 cases -72.7 %
2021 year 11 cases +22.22 %
2020 year 9 cases -60.9 %

Information on important patents (JP)

The following shows JP patents held by 医薬品製剤技術 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 医薬品製剤技術’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.

By noting the most important patents, you can obtain knowledge of the competitive business environment in which 医薬品製剤技術 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.

If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.

Search for Information on Important Patents

You can quickly search for important patents/patent applications, such as patents/patent applications that were cited many times and patents that have had invalidation trials demanded against them many times.

Glossary

Cited
Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
Request for invalidation trial
Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
Opposition
Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
Information provision
Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
Browsing request
Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.

Invalidationed Trial cases

List of latest Invalidationed Trial patents

In the last 3 years (2021-12-01 ~ 2024-11-30), there were 17 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.4 times. The most recently Invalidation Trial patent is 特許5849947 "放出制御医薬組成物" (Invalidation Trial day 2024-09-17) , next is 特許5419866 "新たな医薬組成物" (Invalidation Trial day 2024-05-30) .

Most recent Invalidation Trial (2021-12-01 to 2024-11-30)
- No. Title Invalidation Trial days
1 特許5849947 放出制御医薬組成物 2024-09-17
2 特許5419866 新たな医薬組成物 2024-05-30
3 特許6144713 新たな医薬組成物 2024-05-30
4 特許5735078 新たな医薬組成物 2024-05-30
5 特許6560289 新たな医薬組成物 2024-05-30
6 特許5993471 組成物 2024-03-26
7 特許6445123 癌を治療するための方法及び組成物 2023-11-25
8 特許7194153 新規製剤 2023-07-21
9 特許4171216 含硫化合物と微量金属元素を含む輸液製剤 2023-05-30
10 特許7016341 PD-1軸結合アンタゴニスト及びTIGIT阻害剤を使用するがんの治療方法 2023-03-27

Show 5 patents  

Top Patents/Patent Applications with the Highest Number of Invalidationed Trial

Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 19 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.2. The most invalidation trial patent is 特許6445123 "癌を治療するための方法及び組成物" (5 times) , and the next most invalidation trial patent is 特許6950966 "スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法" (1 times) .

Top Patents/Patent Applications with the Highest Number of Invalidation Trial over a Period of 10 Years (2014-12-01 ~ 2024-11-30)
- No. Title
1 特許6445123 癌を治療するための方法及び組成物 5 times
2 特許6950966 スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法 1 times
3 特許6335326 コンジュゲート化莢膜糖類抗原を含む免疫原性組成物およびその使用 1 times
4 特許6466538 治療薬のCNS送達 1 times
5 特許6522072 イズロン酸−2−スルファターゼのCNS送達のための方法および組成物 1 times

Oppositioned cases

List of latest Oppositioned patents

In the last 3 years (2021-12-01 ~ 2024-11-30), there were 59 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7438604 "SARS-COV-2 mRNAドメインワクチン" (Opposition day 2024-08-23) , next is 特許7429503 "ナットウキナーゼを含む経口組成物" (Opposition day 2024-08-08) .

Most recent Opposition (2021-12-01 to 2024-11-30)
- No. Title Opposition days
1 特許7438604 SARS-COV-2 mRNAドメインワクチン 2024-08-23
2 特許7429503 ナットウキナーゼを含む経口組成物 2024-08-08
3 特許7425603 医薬組成物 2024-07-29
4 特許7425560 固形製剤の製造方法 2024-07-22
5 特許7512762 スガマデクス含有の液体製剤 2024-07-11
6 特許7406226 ウイルス不活性化剤 2024-06-25
7 特許7402687 医薬組成物 2024-06-21
8 特許7366515 外用組成物 2024-04-23
9 特許7376250 皮膚外用組成物 2024-04-20
10 特許7346010 外用組成物 2024-03-19

Show 5 patents  

Protested cases

List of latest Protested patents

In the last 3 years (2021-12-01 ~ 2024-11-30), there were 294 patents Protest from third parties. The average number of Protest is 1.9 times. The most recently Protest patent is 特開2023-052910 "可溶性タンパク質に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩" (Protest day 2024-11-26) , next is 特開2024-096506 "外用製剤" (Protest day 2024-11-12) .

Most recent Protest (2021-12-01 to 2024-11-30)
- No. Title Protest days
1 特開2023-052910 可溶性タンパク質に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩 2024-11-26
2 特開2024-096506 外用製剤 2024-11-12
3 特表2021-522805 hMPCの集団をゼノフリー生成するための方法 2024-11-08
4 特表2024-501951 小胞体ストレス減少用組成物 2024-11-05
5 再公表2019/026992 クロルヘキシジンを含有する医薬組成物 2024-11-01
6 特開2021-059525 水中油型乳化組成物、及び水中油型乳化組成物の液だれ抑制方法 2024-10-31
7 特開2022-070845 浸透促進方法 2024-10-30
8 特開2020-066592 水性貼付剤 2024-10-30
9 特開2022-174508 顆粒の製造方法 2024-10-29
10 特開2022-076151 変色が抑制された経口組成物及びその変色抑制方法 2024-10-25
11 特開2023-075345 眼科組成物およびそれに摩擦低減作用を付与する方法 2024-10-24
12 特開2021-053398 皮膚用貼付材 2024-10-18
13 特開2021-151223 マイオカイン産生促進剤、筋出力増強剤、および筋芽細胞の分化促進剤 2024-10-18
14 特開2021-046394 ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物 2024-10-09
15 特開2021-059524 外用組成物、及び外用組成物におけるヘパリン類似物質の安定化方法 2024-10-04
16 特開2023-033865 口腔用組成物 2024-10-04
17 特開2022-021943 外用組成物、マスク製剤 2024-10-03
18 特開2021-052742 難水溶性物質含有製剤 2024-10-02
19 特開2023-085454 低濃度アトロピン眼科用製剤の安定性を改善するための方法 2024-10-01
20 特開2021-164424 コラーゲン由来の不快臭マスキング剤 2024-10-01

Show 15 patents  

Top Patents/Patent Applications with the Highest Number of Protested

Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 597 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.8. The most protest patent is 特開2020-193227 "外用組成物" (13 times) , and the next most protest patent is 特許7320919 "小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療" (10 times) .

Top Patents/Patent Applications with the Highest Number of Protest over a Period of 10 Years (2014-12-01 ~ 2024-11-30)
- No. Title
1 特開2020-193227 外用組成物 13 times
2 特許7320919 小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療 10 times
3 特開2018-048105 外用組成物 10 times
4 特開2018-177763 トラネキサム酸類配合製剤 9 times
5 特開2018-048104 外用組成物 9 times

Inspectioned cases

List of latest Inspectioned patents

In the last 3 years (2021-12-01 ~ 2024-11-30), there were 872 patents Inspection from third parties. The average number of Inspection is 2.0 times. The most recently Inspection patent is 特表2021-522805 "hMPCの集団をゼノフリー生成するための方法" (Inspection day 2024-11-25) , next is 特開2022-174508 "顆粒の製造方法" (Inspection day 2024-11-22) .

Most recent Inspection (2021-12-01 to 2024-11-30)
- No. Title Inspection days
1 特表2021-522805 hMPCの集団をゼノフリー生成するための方法 2024-11-25
2 特開2022-174508 顆粒の製造方法 2024-11-22
3 特表2022-516318 カプセル化ポリヌクレオチド及び使用方法 2024-11-22
4 特開2022-097486 mRNAの機能状態を変化させてその選択的かつ特異的な認識を可能にする方法 2024-11-14
5 特表2024-501951 小胞体ストレス減少用組成物 2024-11-12
6 特開2023-060159 外用組成物 2024-11-08
7 特表2022-530926 耐薬品性及び耐湿性を有する可撓性基材 2024-11-07
8 特表2024-534353 ヌクレオチド配列合成関連メトリックを生成するためのシステム及び方法 2024-11-06
9 特表2024-512769 抗原特異的T細胞を生成し、疾患を治療するための材料及び方法 2024-11-06
10 特開2023-123469 B型肝炎ウイルス感染のためのRNAi薬 2024-11-06
11 特表2024-532689 ヒドロキシエチルでキャップされたカチオン性ペプトイドを含む組成物 2024-11-06
12 特表2022-504139 バイオフィルムの除去のためのHMGB1タンパク質誘導体 2024-11-05
13 特表2022-516574 新規ペプチドとその使用 2024-11-05
14 特開2024-130578 組成物 2024-11-01
15 特開2020-066592 水性貼付剤 2024-11-01
16 特開2021-042257 BCMA発現に相関性を有する疾患を治療する因子及び方法 2024-11-01
17 特開2024-040421 水性液剤 2024-10-31
18 特開2021-046394 ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物 2024-10-30
19 特開2023-033865 口腔用組成物 2024-10-30
20 特開2022-082777 PEG化薬物リンカー及びその中間体を調製するためのプロセス 2024-10-29

Show 15 patents  

Top Patents/Patent Applications with the Highest Number of Inspectioned

Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 1,590 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.8. The most inspection patent is 特開2018-048105 "外用組成物" (32 times) , and the next most inspection patent is 特許6142892 "経口投与用医薬組成物" (30 times) .

Top Patents/Patent Applications with the Highest Number of Inspection over a Period of 10 Years (2014-12-01 ~ 2024-11-30)
- No. Title
1 特開2018-048105 外用組成物 32 times
2 特許6142892 経口投与用医薬組成物 30 times
3 特許7376250 皮膚外用組成物 30 times
4 特開2018-048104 外用組成物 27 times
5 特許6286383 固形医薬組成物 26 times

Cited cases

Top Patents/Patent Applications with the Highest Number of Cited

Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 5,458 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.1. The most cited patent is 特許6833218 "非血管狭窄のための薬物コーティングされたバルーンカテーテル" (36 times) , and the next most cited patent is 特許5939695 "粘性水系組成物およびその製造方法" (32 times) .

Top Patents/Patent Applications with the Highest Number of Cited over a Period of 10 Years (2014-12-01 ~ 2024-11-30)
- No. Title
1 特許6833218 非血管狭窄のための薬物コーティングされたバルーンカテーテル 36 times
2 特許5939695 粘性水系組成物およびその製造方法 32 times
3 特許6157543 封入薬物組成物およびその使用方法 29 times
4 特許6830671 γ−ヒドロキシ酪酸(GHB)のプロドラッグ、その組成物および使用 28 times
5 特許6756620 薬剤組成物及びコーティング 27 times

Providing patent information to the media (newspapers, magazines, etc.)

"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.

The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.

We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.

About this Site

All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.

Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.

If you have any concerns about this service, please feel free to contact us.

All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.

Please note the following points for use.

e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).

Citation of patent application status and ranking information

There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.

Graphs are image data.

Please note that the various graphs are image data, but we cannot provide them in text data.

Scope of coverage for each goal/target

  • Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
  • A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
  • This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.

About the name collation and name control of applicants and right holders

  • Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
  • Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
  • Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.

Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International

Our Commitment to Safety and Security

Patent Office Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication.
patent information Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence.
reliability of the information Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.